XML 74 R59.htm IDEA: XBRL DOCUMENT v3.26.1
Restructuring, Impairment, and Related Charges, Net - Schedule of Details for Charges Recorded (Details) - USD ($)
$ in Millions
 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2024
Restructuring Cost and Reserve [Line Items]      
Severance and employee-related costs, net $ 25 $ 138 $ 10
Exit and other-related costs 191 108 62
Asset impairments and accelerated depreciation 29 98 43
Total 245 344 115
Restructuring, impairment, and related charges, net 245 286 115
Cost of Sales      
Restructuring Cost and Reserve [Line Items]      
Restructuring, impairment, and related charges, net   58  
Operating Segments | North American Pharmaceutical      
Restructuring Cost and Reserve [Line Items]      
Severance and employee-related costs, net 9 (3) 7
Exit and other-related costs 3 3 3
Asset impairments and accelerated depreciation 12 59 10
Total 24 59 20
Operating Segments | Prescription Technology Solutions      
Restructuring Cost and Reserve [Line Items]      
Severance and employee-related costs, net 3 0 0
Exit and other-related costs 0 3 11
Asset impairments and accelerated depreciation 17 9 0
Total 20 12 11
Operating Segments | Oncology & Multispecialty      
Restructuring Cost and Reserve [Line Items]      
Severance and employee-related costs, net   1 5
Exit and other-related costs   0 1
Asset impairments and accelerated depreciation   0 3
Total 0 1 9
Operating Segments | Medical-Surgical Solutions      
Restructuring Cost and Reserve [Line Items]      
Severance and employee-related costs, net 14 137 (1)
Exit and other-related costs 37 53 12
Asset impairments and accelerated depreciation (8) 14 0
Total 43 204 11
Corporate & Other      
Restructuring Cost and Reserve [Line Items]      
Severance and employee-related costs, net (1) 3 (1)
Exit and other-related costs 151 49 35
Asset impairments and accelerated depreciation 8 16 30
Total $ 158 $ 68 $ 64